← Evidence map

ReviewDrugs2019

Recent Developments in LRRK2-Targeted Therapy for Parkinson's Disease.

Ye Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

30 papers cite it

2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31161537